[1]闫秋芳,杨继闽.梗阻性结直肠癌患者的临床病理特点及生存状况分析[J].新乡医学院学报,2019,36(7):673-676.[doi:10.7683/xxyxyxb.2019.07.018]
　YAN Qiu-fang,YANG Ji-min.Analysis of clinicopathological features and survival status of patients with obstructive colorectal cancer[J].Journal of Xinxiang Medical University,2019,36(7):673-676.[doi:10.7683/xxyxyxb.2019.07.018]
点击复制

梗阻性结直肠癌患者的临床病理特点及生存状况分析
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年7
页码:
673-676
栏目:
临床研究
出版日期:
2019-07-05

文章信息/Info

Title:
Analysis of clinicopathological features and survival status of patients with obstructive colorectal cancer
作者:
闫秋芳; 杨继闽
（濮阳市油田总医院肛肠科，河南　濮阳　457001）
Author(s):
YAN Qiu-fang; YANG Ji-min
(Department of Anorectal Disease,Puyang Oilfield General Hospital,Puyang 457001,Henan Province,China)
关键词:
梗阻性结直肠癌; 临床病理特征; 生存状况
Keywords:
obstructive colorectal cancer; clinicopathological features; survival status
分类号:
R735.3+4
DOI:
10.7683/xxyxyxb.2019.07.018
文献标志码:
A
摘要:
目的　探讨梗阻性结直肠癌患者的临床病理特点与生存状况。方法　选择2010年1月至2015年1月濮阳市油田总医院收治的654例结直肠癌患者为研究对象，其中梗阻性结直肠癌327例，非梗阻性结直肠癌327例。采集患者的临床资料，总结梗阻性结直肠癌患者的临床病理特点与生存状况，分析结直肠癌患者发生肠梗阻的相关因素，采用logistic回归分析梗阻性结直肠癌患者死亡的危险因素。结果　肿瘤部位、肿瘤N分期、肿瘤直径、Dukes分期、组织分化程度与结直肠癌患者发生肠梗阻有关（P<0.05），而患者年龄、性别、首发症状、肿瘤T分期、肿瘤沉积、脉管癌栓或神经侵犯及肿瘤大体形态与结直肠癌患者发生肠梗阻无关（P>0.05）。术后1 a，梗阻性结直肠癌患者复发率、转移率、病死率分别为6.87%（20/291）、4.81%（14/291）、11.68%（34/291），非梗阻性结直肠癌患者复发率、转移率、病死率分别为3.84%（11/286）、2.09%（6/286）、5.94%（17/286）；术后3 a，梗阻性结直肠癌患者复发率、转移率、病死率分别为28.52%（83/291）、14.43%（42/291）、36.08%（105/291），非梗阻性结直肠癌患者复发率、转移率、病死率分别为16.78%（48/286）、5.24%（15/286）、18.18%（52/286）；梗阻性结直肠癌患者术后1、3 a复发率、转移率、病死率显著高于非梗阻性结直肠癌患者（P<0.05）。溃疡型结直肠癌、Dukes分期C期、肿瘤组织低分化、腹水、复发、转移、术后无化学治疗是梗阻性结直肠癌患者死亡的危险因素（P<0.05）。结论　肿瘤部位、肿瘤N分期、组织分化程度与结直肠癌患者发生肠梗阻有关，梗阻性结直肠癌患者术后复发率、转移率和病死率较高，溃疡型结直肠癌、Dukes分期C期、肿瘤组织低分化、腹水、复发、转移、术后无化学治疗是梗阻性结直肠癌患者死亡的危险因素。
Abstract:
Objective　To investigate the clinicopathological features and survival status of patients with obstructive colorectal cancer.Methods　A total of 654 patients with colorectal cancer admitted to Puyang Oilfield General Hospital from January 2010 to January 2015 were selected as the study subjects,including 327 cases of obstructive colorectal cancer and 327 cases of non-obstructive colorectal cancer.The clinical data of the patients were collected to summarize the clinicopathological characteristics and survival status of patients with obstructive colorectal cancer,and analyze the related factors of intestinal obstruction.The risk factors of death in patients with obstructive colorectal cancer were analyzed by logistic regression.Results　The tumor location,N-staging of tumors,tumor diameter,Dukes stage and histological differentiation were related to the occurrence of intestinal obstruction in patients with colorectal cancer (P<0.05).The age,sex,initial symptoms,T-staging of tumors,tumor deposition,cancer thrombus of vascular or nerve invasion,and tumor gross appearance were not related to the occurrence of intestinal obstruction in patients with colorectal cancer (P>0.05).One year after operation,the recurrence rate,metastasis rate and fatality rate of patients with obstructive colorectal cancer were 6.87% (20/291),4.81% (14/291) and 11.68% (34/291),respectively;and they were 3.84% (11/286),2.09% (6/286) and 5.94% (17/286) in patients with non-obstructive colorectal cancer,respectively.Three years after operation,the recurrence rate,metastasis rate and fatality rate of patients with obstructive colorectal cancer were 28.52% (83/291),14.43% (42/291) and 36.08% (105/291),respectively;and they were 16.78% (48/286),5.24% (15/286) and 18.18% (52/286) in patients with non-obstructive colorectal cancer,respectively.The postoperative 1- and 3-year recurrence rate,metastasis rate and fatality rate of patients with obstructive colorectal cancer were significantly higher than those in patients with non-obstructive colorectal cancer (P<0.05).Ulcerative colorectal cancer,Dukes C-staging,poor differentiation of tumor tissue,ascites,recurrence,metastasis,and no chemotherapy after operation were the risk factors for death in patients with obstructive colorectal cancer (P<0.05).Conclusion　The tumor location,T-staging of tumors and tissue differentiation are related to intestinal obstruction in patients with colorectal cancer.The postoperative recurrence rate,metastasis rate and mortality rate of patients with obstructive colorectal cancer are higher.Ulcerative colorectal cancer,Dukes C-staging,poor differentiation of tumor tissue,ascites,recurrence,metastasis,and no chemotherapy after operation are the risk factors for death in patients with obstructive colorectal cancer.

参考文献/References:

［1］　陈晓燕，罗金键.CXCL8 在结直肠癌组织中的表达及其临床意义［J］.新乡医学院学报，2018，35 （6）：505-508.
［2］　ERICHSEN R,HORVTH-PUH E,JACOBSEN J B,et al.Long-term mortality and recurrence after colorectal cancer surgery with preoperative stenting:a Danish nationwide cohort study ［J］.Endoscopy,2015,47(6):517-524.
［3］　夏建福，周宏，李日增，等.支架联合腹腔镜治疗老年梗阻性结直肠癌的临床疗效［J］.中华老年医学杂志，2017，36（12）：1326-1329.
［4］　MAJBAR M A,NAYA M S,ELALAOUI M,et al.Cecal recurrence after one-stage resection of obstructive rectal cancer with intraoperative colonic lavage through the appendix:a curious coincidence［J］.Int J Colorectal Dis,2015,30(3):425-426.
［5］　卢清平，兰启龙，陈龙，等.内镜下金属支架联合择期腹腔镜手术在梗阻性结直肠癌中的应用［J］.中华胃肠外科杂志，2017，20（6）：684-688.
［6］　赵锐，包郁，周凌霄，等.无透视下经肠镜安置肠道支架在结直肠癌梗阻治疗中的应用［J］.中华消化内镜杂志，2017，34（8）：590-591.
［7］　TAKAHASHI H,OKABAYASHI K,TSURUTA M,et al.Self-expanding metallic stents versus surgical intervention as palliative therapy for obstructive colorectal cancer:a meta-analysis［J］.World J Surg,2015,39(8):2037-2044.
［8］　蒋华东，顾庆春，朱荣荣，等.MSCT对结肠癌术前诊断及分期的临床价值［J］.中国中西医结合影像学杂志，2016，14（1）：31-33.
［9］　陈路川，魏晟宏，叶再生，等.吻合口与非吻合口处残胃癌的临床病理学特征及预后的差异研究［J］.中华胃肠外科杂志，2017，20（1）：67-72.
［10］　王红旭，张继东，李东平，等.结直肠癌同时合并腹水的临床病理特点及其预后分析［J］.中国当代医药，2016，23（2）：42-46.
［11］　张勇，许建华，孙珏，等.健脾解毒方联合FOLFOX4方案治疗晚期结直肠癌临床研究［J］.环球中医药，2010，3（2）：117-120.

相似文献/References:

[1]王璧,王战会,韩保卫,等.Runt相关转录因子3在结直肠癌组织中的表达及意义[J].新乡医学院学报,2022,39(12):1127.[doi:10.7683/xxyxyxb.2022.12.005]
　WANG Bi,WANG Zhanhui,HAN Baowei,et al.Expression and significance of Runt-related transcription factor 3 in colorectal cancer[J].Journal of Xinxiang Medical University,2022,39(7):1127.[doi:10.7683/xxyxyxb.2022.12.005]
[2]王　雷１,王煜霞２,薛会朝１. 肝癌患者肿瘤坏死因子α和白细胞介素８水平变化及其与临床病理特征的关系[J].新乡医学院学报,2015,32(08):735.
[3]张建东,贺利民,马　磊,等.表皮生长因子受体基因突变和切除修复交叉互补蛋白1蛋白表达与肺腺癌患者临床病理特征及预后的关系[J].新乡医学院学报,2016,33(10):894.[doi:10.7683/xxyxyxb.2016.10.015]
　ZHANG Jian-dong,HE Li-min,MA Lei,et al.Relation of expression of epidermal growth factor receptor genic mutation&excision repair cross complementing protein1 with clinicopathological features&prognosis in pulmonary adenocarcinoma patients[J].Journal of Xinxiang Medical University,2016,33(7):894.[doi:10.7683/xxyxyxb.2016.10.015]
[4]盖守娟.细胞周期蛋白依赖性激酶抑制因子2A基因表达与胰腺癌临床病理特征的关系[J].新乡医学院学报,2021,38(6):573.[doi:10.7683/xxyxyxb.2021.06.016]
　GAI Shoujuan.Relationship between the expression of cyclin-dependent kinase inhibitor 2A gene and clinicopathological features of pancreatic cancer[J].Journal of Xinxiang Medical University,2021,38(7):573.[doi:10.7683/xxyxyxb.2021.06.016]
[5]李　军.不同年龄前列腺癌患者的临床病理特征与生存状况分析[J].新乡医学院学报,2020,37(9):862.[doi:10.7683/xxyxyxb.2020.09.013]
　LI Jun.Clinicopathological characteristics and survival status of prostate cancer patients at different ages[J].Journal of Xinxiang Medical University,2020,37(7):862.[doi:10.7683/xxyxyxb.2020.09.013]
[6]刘思哲,安万花,郭淑利,等.锌指蛋白382在弥漫大B细胞淋巴瘤组织中的表达及临床意义[J].新乡医学院学报,2024,(1):037.[doi:10.7683/xxyxyxb.2024.01.007]
　LIU Sizhe,AN Wanhua,GUO Shuli,et al.Expression and clinical significance of zinc finger protein 382 in diffuse large B-cell lymphoma[J].Journal of Xinxiang Medical University,2024,(7):037.[doi:10.7683/xxyxyxb.2024.01.007]
[7]姜黄,郑丽华,徐小艳,等.细胞外基质金属蛋白酶诱导因子、基质金属蛋白酶-9和赖氨酸去甲基化酶6B在浸润性乳腺癌组织中的表达及其病理诊断价值[J].新乡医学院学报,2024,(2):143.[doi:10.7683/xxyxyxb.2024.02.008]
　JIANG Huang,ZHENG Lihua,XU Xiaoyan,et al.Expression and pathological diagnostic value of extracellular matrix metalloproteinase inducer,matrix metalloproteinase-9 and lysine demethylase 6B in invasive breast cancer[J].Journal of Xinxiang Medical University,2024,(7):143.[doi:10.7683/xxyxyxb.2024.02.008]

更新日期/Last Update: 2019-07-05